Syrris creates Orb Pilot for effortless reaction scale-up
28 September 2016 | By Syrris
Syrris, a world leader in chemistry product innovation, is launching the Orb Pilot jacketed reactor this fall...
List view / Grid view
News
Moberg begins patient enrolment in US and Europe Phase 3 onychomycosis trials
28 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Approximately 10% of the general population suffer from onychomycosis and a majority of those afflicted go untreated. The prescription market is growing...
Bristol-Myers Squibb and Nektar Therapeutics to combine oncology therapies
28 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Bristol-Myers' Opdivo is a PD-1 immune checkpoint inhibitor designed to overcome immune suppression and NKTR-214 is an immuno-stimulatory therapy...
EryTech completes patient enrolment in Phase 2 pancreatic cancer trial
28 September 2016 | By Niamh Louise Marriott, Digital Content Producer
For the treatment of pancreatic cancer, EryTech are now looking to develop 'tumour starvation' treatments for acute leukaemia and have enrolled their...
AbbVie’s 8 week clinical trial speedy and successful for 98% of Hep C patients
28 September 2016 | By Niamh Louise Marriott, Digital Content Producer
The primary endpoint of the trial being the percentage of patients who achieved a sustained virologic response 12 weeks after treatment (SVR12)...
NICE recommends new rare inherited bone disorder drug for children
28 September 2016 | By Niamh Louise Marriott, Digital Content Producer
The drug is the first treatment to target hypophosphatasia, a condition affecting the development of bone, and could allow children to lead a normal life...
Expanded use for Novartis’ Periodic Fever Syndrome drug after 3 new FDA approvals
27 September 2016 | By Niamh Louise Marriott, Digital Content Producer
The expanded use is for Ilaris, a selective, high-affinity, human monoclonal antibody that inhibits Interleukin-1 (IL-1) beta, part of the immune system...
First traditional-use registration for St John’s Wort and Valerian combination
27 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Until now, the time-consuming marketing authorisation process was the only path to being able to market products containing St John’s Wort and Valerian...
BARDA grants Sanofi $43.2 million for Zika vaccine development
27 September 2016 | By Niamh Louise Marriott, Digital Content Producer
In July, Sanofi revealed the development agreement with the Walter Reed Army Institute of Research on the co-development of a Zika vaccine candidate...
Abeona enrols first Phase 2 patient following successful Phase 1 Epidermolysis trial
27 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Also known as "Butterfly skin" syndrome, epidermolysis bullosa (EB) is a rare genetic skin disease that is caused by the absence of a gene (COL7A1)...
Triplet-exciton energy transfer from semiconductor nanocrystals demonstrated using Edinburgh Instruments systems
26 September 2016 | By Edinburgh Instruments
Researchers at North Carolina State University, led by Prof. Felix Castellano, have shown for the first time that the photogenerated triplet exciton in semiconductor nanocrystals can be harvested by surface bound molecular acceptors, exhibited by a six-order magnitude increase in the lifetime of the originally prepared excited state...
Wickham Laboratories now offering stability storage & testing
23 September 2016 | By Wickham Laboratories Limited
Wickham Laboratories is pleased to introduce stability storage and testing as its latest service offering...
Joint article on hydrogen peroxide efficacy published in Letters in Applied Microbiology
23 September 2016 | By Wickham Laboratories Limited
Wickham Laboratories Ltd is pleased to announce the publication of a joint study with Bioquell on the efficacy of disinfection by hydrogen peroxide...
BBI Solutions launches innovative conjugate blocking technology that enhances signal intensity for lateral flow immunoassays
23 September 2016 | By BBI Solutions
BBI Solutions has launched Morffi™, a novel conjugate blocking technology that enhances signal intensity and improves the sensitivity of lateral flow immunoassays, at the Lateral Flow Test Development seminar in Seattle, USA, on the 20th September...
RB implements Ci-DMS Weigh and Dispense from CI Precision
23 September 2016 | By CI Precision
Global consumer goods group RB (formerly known as Reckitt Benckiser) is implementing CI Precision’s MES solution (Ci-DMS) in the dispensing area at their manufacturing plant in Pakistan...
